Institutional Repository of Vilnius University
XVII-osios Lietuvos Respublikos Vyriausybės vaistų kompensavimo reformos efektyvumo vertinimas /
Abstract
dc:descriptionThe work assesses the 2017-2020 reform of reimbursable medicines in Lithuania by combining time-series financial data and legislative analysis. The reform has more than halved the average patient's prescription premium and increased the cost of medicines to the PSDF, but has been contained by tighter pricing and generic incentives. The extension of free medicines to seniors and low-income patients has reduced the risk of catastrophic health costs, and the 2021 Constitutional Court ruling has strengthened legal clarity. The case of Lithuania shows that a small market can reduce the financial burden on patients while maintaining budgetary sustainability.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Domarkas, Šarūnas,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD239018677&prefLang=en_US